Pharmacodynamics of Antibiotics
Pharmacodynamics of Antibiotics
Pharmacodynamics of Antibiotics
Antibiotics
Hail M. Al-Abdely, MD
Concepts
Pharmacokinetics
describe how drugs behave in the human host
Pharmacodynamics
the relationship between drug concentration
and antimicrobial effect. Time course of
antimicrobial activity
Concepts
Minimum Inhibitory Concentration (MIC)
The lowest concentration of an antibiotic that inhibits
bacterial growth after 16-20 hrs incubation.
C-p
Peak antibiotic concentration
Antimicrobial-micro-organism
interaction
Antibiotic must reach the binding site of
the microbe to interfere with the life cycle.
Antibiotic must occupy sufficient number
of active sites.
Antibiotic must reside on the active site for
sufficient time. Antibiotics are not contact
poisons.
CFU
Static
Cidal
Time
Questions
Can this antibiotic inhibit/kill these bacteria?
Can this antibiotic reach the site of bacterial replication?
What concentration of this antibiotic is needed to
inhibit/kill bacteria?
Will the antibiotic kill better or faster if we increase its
concentration?
Do we need to keep the antibiotic concentration always
high throughout the day?
Conc
MIC
Time
greater killing
Time-dependent killing
Minimal concentration-dependent killing (4x
MIC)
More exposure
more killing
Beta lactams, glycopeptides, clindamycin,
macrolides, tetracyclines, bactrim
Persistent Effects
Persistent suppression of bacterial growth
following antimicrobial exposure.
Moderate to prolonged against all GM
positives (In vitro)
Moderate to prolonged against GM negatives
for protein and nucleic acid synthesis
inhibitors.
Minimal or non against GM negatives for beta
lactams (except carabapenems against P.
aeruginosa)
Persistent Effects
Post-antibiotic sub-MIC effect.
Prolonged drug level at sub-MIC augment the
post-antibiotic effect.
Examples
Aminoglycosides, Flouroquinolones, Ketolides,
metronidazole, Ampho B.
Examples
Beta lactam, macrolides, clindamycin, flucytosine,
linezolid.
Examples
Azithromycin, vancomycin, tetracyclines,
fluconazole.
PK/PD patterns
C-p
C-p
Concentration
MIC
AUC
AUC
Time
Tobramycin
Log 10 CFU/ml
Ticarcillin
Hours
Ciprofloxacin
Log 10 CFU/thigh
10
100
1000
24hr AUC/MIC
10
100
Peak/MIC
1000
25
50
75
100
Log 10 CFU/thigh
10
100
1000
24hr AUC/MIC
10
100
Peak/MIC
1000
25
50
75
100
Log 10 CFU/thigh
Ceftazidime
10
100
10001
100
Peak/MIC
10000
25
50
75
100
Log 10 CFU/thigh
24hr AUC/MIC
10
Temafloxacin
10
100
10001
24hr AUC/MIC
10
100
Peak/MIC
10000
25
50
75
100
100
Penicillin
Cephalosporins
80
Mortality%
60
40
20
0
20
40
60
80
100
100
80
Mortality%
60
40
20
0
10
24hr AUC/MIC
100
1000
Human Data
Percentage bacteriologic cure for -lactam agents against Streptococcus pneumoniae (black
circle) and Haemophilus influenzae (white circle) in children with acute otitis media
Craig WA, Andes W.. Pediatr Infect Dis J 1996;15:255-9.
Beta lactams
MIC
Time
Aminoglycosides
C-p
MIC
Time
Fluoroquinolones
C-p
AUC
MIC
Time
Glycopeptides
C-p
AUC
MIC
Time
Old NCCLS
Breakpoint
PD
(T>MIC>40%)
New NCCLS
Breakpoints
0.5
Cefaclor
0.5-1
Cefprozil
1-2
Cefpodoxime
0.5
0.5
0.5
Cefuroxime